Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna Panizzutti

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Pharmaceutics|July 27, 2022
Repurposing Drugs via Network Analysis: Opportunities for Psychiatric DisordersTrang T T Truong, Bruna Panizzutti, Jee Hyun Kim, et al.
Expert Opinion on Therapeutic Targets|March 25, 2014
Progesterone and its metabolites as therapeutic targets in psychiatric disordersGiovana Bristot, Bruna Ascoli, Carolina Gubert, et al.
Biological Psychiatry|February 15, 2025
The Drug Discovery Drought in Bipolar Disorder: Barriers and SolutionsJee Hyun Kim, Ken Walder, Bruna Panizzutti, et al.
The Lancet. Psychiatry|April 26, 2025
A novel discovery platform for targeted drug repurposing: application for psychiatric disordersMichael Berk, Jee Hyun Kim, Lana J Williams, et al.
Journal of Affective Disorders|January 8, 2024
Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorderTrang T T Truong, Zoe S J Liu, Bruna Panizzutti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 6, 2024
Network-based drug repurposing for schizophreniaTrang T T Truong, Zoe S J Liu, Bruna Panizzutti, et al.
Expert Review of Neurotherapeutics|August 1, 2013
Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorderBianca Pfaffenseller, Gabriel R Fries, Bianca Wollenhaupt-Aguiar, et al.
Schizophrenia Bulletin|March 25, 2017
Telomere Length and CCL11 Levels are Associated With Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated AgingLeticia Sanguinetti Czepielewski, Raffael Massuda, Bruna Panizzutti, et al.
Journal of Psychopharmacology (Oxford, England)|January 9, 2020
Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowthSrisaiyini Kidnapillai, Ben Wade, Chiara C Bortolasci, et al.
Acta Neuropsychiatrica|March 21, 2017
Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factorKyoko Hasebe, Laura Gray, Chiara Bortolasci, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Pharmaceutics|July 27, 2022
Repurposing Drugs via Network Analysis: Opportunities for Psychiatric DisordersTrang T T Truong, Bruna Panizzutti, Jee Hyun Kim, et al.
Expert Opinion on Therapeutic Targets|March 25, 2014
Progesterone and its metabolites as therapeutic targets in psychiatric disordersGiovana Bristot, Bruna Ascoli, Carolina Gubert, et al.
Biological Psychiatry|February 15, 2025
The Drug Discovery Drought in Bipolar Disorder: Barriers and SolutionsJee Hyun Kim, Ken Walder, Bruna Panizzutti, et al.
The Lancet. Psychiatry|April 26, 2025
A novel discovery platform for targeted drug repurposing: application for psychiatric disordersMichael Berk, Jee Hyun Kim, Lana J Williams, et al.
Journal of Affective Disorders|January 8, 2024
Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorderTrang T T Truong, Zoe S J Liu, Bruna Panizzutti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 6, 2024
Network-based drug repurposing for schizophreniaTrang T T Truong, Zoe S J Liu, Bruna Panizzutti, et al.
Expert Review of Neurotherapeutics|August 1, 2013
Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorderBianca Pfaffenseller, Gabriel R Fries, Bianca Wollenhaupt-Aguiar, et al.
Schizophrenia Bulletin|March 25, 2017
Telomere Length and CCL11 Levels are Associated With Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated AgingLeticia Sanguinetti Czepielewski, Raffael Massuda, Bruna Panizzutti, et al.
Journal of Psychopharmacology (Oxford, England)|January 9, 2020
Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowthSrisaiyini Kidnapillai, Ben Wade, Chiara C Bortolasci, et al.
Acta Neuropsychiatrica|March 21, 2017
Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factorKyoko Hasebe, Laura Gray, Chiara Bortolasci, et al.
Pageof 4